Are you or someone you love affected by systemic mastocytosis or breast, endometrial, lung, ovarian, or thyroid cancer?

If you are interested in being part of a Blueprint Medicines Patient Council, please fill out the short survey. We want to have a diverse group of participants, so we cannot choose everyone. We will let you know if we have a position available for you, or if we have other opportunities to be involved. Blueprint Medicines is working with its agency partner VOZ Advisors on this project; someone from VOZ Advisors will be in touch.

VOZ is working with Blueprint Medicines to identify patients, caregivers, and advocates to participate on Patient Councils

Blueprint Medicines Patient Councils are groups that consist of patients, caregivers, and advocates.  Patient Council members help Blueprint by bringing the patient voice into the drug development process across various important phases—discovery, clinical development, approvals, launch, and post-launch. 

Furthermore, Patient Council members help ensure that patient-facing programs, such as communications, education, and patient services, are easily understood and relevant to the community. By working with Patient Councils, Blueprint Medicines wants to identify ways to find what is important to patients and further include patient voices into their business. 

Patient Councils consist of up to 12 patients, caregivers, or advocates with diverse backgrounds (e.g., race, gender, and geography) that reflect the patient community for a specific disease. Generally, members may serve yearly for up to three years based on needs, and Councils meet multiple times a year (in-person or virtually).

If you are interested in being part of a Blueprint Medicines Patient Council, please fill out this short survey.

To learn more about this opportunity, please provide your contact information and VOZ Advisors will contact you, or contact Maya at VOZ Advisors (